Literature DB >> 32189309

High-Density Lipoproteins and Apolipoprotein A1.

Emiel P C van der Vorst1,2,3,4.   

Abstract

High-density lipoprotein (HDL) and its main protein component apolipoprotein (apo)A-I, play an important role in cholesterol homeostasis. It has been demonstrated that HDLs comprise of a very heterogeneous group of particles, not only regarding size but also composition. HDL's best described function is its role in the reverse cholesterol transport, where lipid-free apoA-I or small HDLs can accept and take up cholesterol from peripheral cells and subsequently transport this to the liver for excretion. However, several other functions have also been described, like anti-oxidant, anti-inflammatory and anti-thrombotic effects. In this article, the general features, synthesis and metabolism of apoA-I and HDLs will be discussed. Additionally, an overview of HDL functions will be given, especially in the context of some major pathologies like cardiovascular disease, cancer and diabetes mellitus. Finally, the therapeutic potential of raising HDL will be discussed, focussing on the difficulties of the past and the promises of the future.

Entities:  

Keywords:  Apolipoprotein A1; High-density lipoproteins (HDLs); Lipid metabolism; Therapy

Mesh:

Substances:

Year:  2020        PMID: 32189309     DOI: 10.1007/978-3-030-41769-7_16

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  12 in total

1.  Proteomic Profiling of Aqueous Humor Exosomes from Age-related Macular Degeneration Patients.

Authors:  Ching-Yao Tsai; Chueh-Tan Chen; Hsin-Han Wu; Chen-Chung Liao; Kate Hua; Chung-Hua Hsu; Chian-Feng Chen
Journal:  Int J Med Sci       Date:  2022-05-13       Impact factor: 3.642

2.  Urinary Protein Array Analysis to Identify Key Inflammatory Markers in Children with IgA Vasculitis Nephritis.

Authors:  Julien Marro; Andrew J Chetwynd; Rachael D Wright; Silothabo Dliso; Louise Oni
Journal:  Children (Basel)       Date:  2022-04-27

Review 3.  Nanodiscs: A toolkit for membrane protein science.

Authors:  Stephen G Sligar; Ilia G Denisov
Journal:  Protein Sci       Date:  2020-11-16       Impact factor: 6.993

Review 4.  Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease.

Authors:  Cristina Bauset; Laura Gisbert-Ferrándiz; Jesús Cosín-Roger
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

5.  Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study.

Authors:  Liang Gao; Yaju Zhang; Xingmin Wang; Hongli Dong
Journal:  BMC Endocr Disord       Date:  2021-04-01       Impact factor: 2.763

6.  Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease.

Authors:  Changxi Chen; Hongliang Li; Jian Song; Cheng Zhang; Mengting Li; Yushan Mao; Aiming Liu; Juan Du
Journal:  PPAR Res       Date:  2022-02-18       Impact factor: 4.964

7.  Cross-sectional and longitudinal associations of apolipoprotein A1 and B with glycosylated hemoglobin in Chinese adults.

Authors:  Hongli Dong; Wenqing Ni; Yamin Bai; Xueli Yuan; Yan Zhang; Hongmin Zhang; Yuanying Sun; Jian Xu
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.996

8.  Angiogenin Levels and Their Association with Cardiometabolic Indices Following Vitamin D Status Correction in Saudi Adults.

Authors:  Ghadeer M Aldawsari; Shaun Sabico; Abir A Alamro; Amal Alenad; Kaiser Wani; Abdullah M Alnaami; Malak N K Khattak; Mohammad S Masoud; Nasser M Al-Daghri; Majed S Alokail
Journal:  Biology (Basel)       Date:  2022-02-11

Review 9.  Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis.

Authors:  Marco Zuin; Carlo Cervellati; Alessandro Trentini; Angelina Passaro; Valentina Rosta; Francesca Zimetti; Giovanni Zuliani
Journal:  Diagnostics (Basel)       Date:  2021-05-28

10.  A short peptide of the C-terminal class Y helices of apolipoprotein A-I has preserved functions in cholesterol efflux and in vivo metabolic control.

Authors:  Shelley J Edmunds; Rebeca Liébana-García; Karin G Stenkula; Jens O Lagerstedt
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.